Ralston J S, Main A R, Kilpatrick B F, Chasson A L
Biochem J. 1983 Apr 1;211(1):243-50. doi: 10.1042/bj2110243.
Two large-scale methods based primarily on the use of procainamide-Sepharose gels were developed for the purification of horse and human serum non-specific cholinesterases. With method I, the procainamide-Sepharose 4B gel was used in the first step to handle large volumes of serum. With method II, the procainamide-Sepharose 4B gel was used in the final step to obtain pure enzyme. Although both methods gave electrophoretically pure cholinesterase preparations in good yields, they were significantly more efficient at purifying the horse enzyme than the human enzyme. To study this problem, the relative binding of human and horse cholinesterases to procainamide-, methylacridinium (MAC)-, m-trimethylammoniophenyl (m-PTA)- and p-trimethylammoniophenyl (p-PTA)-Sepharose 4B gels were measured, by using two approaches. In one, binding was measured by a procedure involving equilibration of pure cholinesterase in a small volume of diluted gel slurry (4%, v/v). A partially purified preparation of Electrophorus acetylcholinesterase was included. Pure human cholinesterase bound consistently more tightly to each of the gels than did horse cholinesterase, and the acetylcholinesterase appeared to bind the gels 10-100 times more tightly than did the non-specific cholinesterases. The order of binding for the cholinesterases, beginning with the tightest, was: procainamide-Sepharose 4B, MAC-Sepharose 4B, p-PTA-Sepharose 4B and m-PTA-Sepharose 4B. For the acetylcholinesterase the order was: MAC-Sepharose 4B, procainamide-Sepharose 4B, p-PTA-Sepharose 4B and m-PTA-Sepharose 4B. The second approach involved passing native sera or partially purified sera fractions through 1 ml test columns of each of the four affinity gels to determine their retention capacity for the cholinesterases. With these impure samples, the MAC-Sepharose 4B gels proved superior to the procainamide-Sepharose 4B gels at retaining human cholinesterase, but the opposite was true for the horse cholinesterase.
开发了两种主要基于使用普鲁卡因酰胺 - 琼脂糖凝胶的大规模方法来纯化马和人血清非特异性胆碱酯酶。方法I中,第一步使用普鲁卡因酰胺 - 琼脂糖4B凝胶处理大量血清。方法II中,最后一步使用普鲁卡因酰胺 - 琼脂糖4B凝胶获得纯酶。虽然两种方法都能以高收率得到电泳纯的胆碱酯酶制剂,但它们在纯化马酶方面比人酶显著更有效。为研究此问题,采用两种方法测量了人和马胆碱酯酶与普鲁卡因酰胺 - 、甲基吖啶鎓(MAC) - 、间三甲铵基苯基(m - PTA) - 和对三甲铵基苯基(p - PTA) - 琼脂糖4B凝胶的相对结合。一种方法是通过在少量稀释的凝胶浆液(4%,v/v)中平衡纯胆碱酯酶的程序来测量结合。其中包括部分纯化的电鳗乙酰胆碱酯酶制剂。纯人胆碱酯酶与每种凝胶的结合始终比马胆碱酯酶更紧密,并且乙酰胆碱酯酶与凝胶的结合似乎比非特异性胆碱酯酶紧密10 - 100倍。胆碱酯酶的结合顺序,从最紧密开始,为:普鲁卡因酰胺 - 琼脂糖4B、MAC - 琼脂糖4B、p - PTA - 琼脂糖4B和m - PTA - 琼脂糖4B。对于乙酰胆碱酯酶,顺序为:MAC - 琼脂糖4B、普鲁卡因酰胺 - 琼脂糖4B、p - PTA - 琼脂糖4B和m - PTA - 琼脂糖4B。第二种方法是将天然血清或部分纯化的血清组分通过四种亲和凝胶中每种的1 ml测试柱,以确定它们对胆碱酯酶的保留能力。对于这些不纯样品,MAC - 琼脂糖4B凝胶在保留人胆碱酯酶方面优于普鲁卡因酰胺 - 琼脂糖4B凝胶,但对于马胆碱酯酶则相反。